Interview with Michael Azrak, Managing Director, MSD South Africa
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa, you are in the…
Adcock Ingram is a leading South African pharmaceutical manufacturer, listed on the Johannesburg Stock Exchange.
The Company manufactures, markets and distributes a wide range of healthcare products. The company is a leading supplier to both the private and public sectors of the market.
Adcock Ingram is a level 3 B-BBEE contributor.
Adcock Ingram Specialized Therapies is a specialized division that focuses on inspired therapeutic solutions, delivered through innovation that adds value to life, for life.
We provide leadership through solutions that support healthcare professionals to provide best-in-class specialist solutions for comprehensive patient care and the world’s leading and most trusted therapeutic brands.
The Prescription product range comprises medicines and technologies promoted to the healthcare professionals only. This portfolio includes a comprehensive range of generic medicines including antiretroviral medicines (ARVs). Partnerships with multinational pharmaceutical companies continue to augment the comprehensive portfolio of originator medicines.
Contact Details
Telephone: +27 11 635 0000
Physical address:
1 New Road,
Midrand 1685
South Africa
Postal address:
Private Bag X69,
Bryanston 2021
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa, you are in the…
Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes in the market since…
South Africa is at the moment one of the world’s most exciting and dynamic markets at the moment as Mr. Omar Ehsan was telling us, the most exciting market he…
Could you introduce to our readers MC Pharma’s business model in the South African market as well as the main milestones in the company’s development over the recent years? MC…
Mr. Daniel, after working with Pfizer Australia, working in Hong Kong as Regional Marketing Director for the Asian operation and in Japan, you have been the first South African appointed…
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day by half – but…
Our international readers know about South Africa’s socio-economic relative achievements, considering the country joined the BRICS grouping last year and achieved the first Millennium Development Goal (MDG) that same year.…
Mr Kahanovitz, Focus Reports came to South Africa in 2005 to produce a similar report on the South African pharmaceutical industry. Could you come back for us on the main…
Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare reforms… How have you integrated these changes…
Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations as the General Manager of…
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic companies climb up the…
Mr. Godard, you previously worked in Europe for Baxter Edwards Life Sciences, what made you decide to move to South Africa in a smaller company? It is a purely romantic…
See our Cookie Privacy Policy Here
